Digoxin: all 146 studies that test it

Page 2 of 2. Open to participants first (10), then studies with results posted, then the rest; newest registration first within each.

• Pharmacokinetic and Safety Study of Cenicriviroc and HMG-CoA Reductase Inhibitors, Caffeine and DigoxinCompletedNCT02685462Phase 1
• A Drug-drug Interaction (DDI) Study to Assess the Effect of INC280 on the Pharmacokinetics of Digoxin and Rosuvastatin in Patients With cMET-dysregulated Advanced Solid TumorsCompletedNCT02626234Phase 1
• Prospective Randomized Clinical Trial of Fetal Atrial Flutter & Supraventricular Tachycardia Therapy (FAST RCT)CompletedNCT02624765Phase 3
• Digoxin Short Term Treatment Assessment Randomized Trial in AHFCompletedNCT02544815Phase 3
• Evaluate the Pharmacokinetics of Digoxin When Coadministered With PEX168 in Healthy Adult SubjectsCompletedNCT02472236Phase 1
• Study to Investigate the Effect of BMS-986142 on the Pharmacokinetics (PK) of Methotrexate and Probe Substrate Cocktail in Healthy PatientsCompletedNCT02456844Phase 1
• The Pharmacokinetic Study of the Combination of Digoxin and Polythylene Glycol Loxenatide Injection in Healthy SubjectsCompletedNCT02451527Phase 1
• An Open Label, Single Dose, Three Part Study to Assess the Effects of Rolapitant (2 mg/mL IV Solution) on the Pharmacokinetics of Digoxin; Sulfasalazine; and the Cooperstown Cocktail (Midazolam, Omeprazole, Warfarin, Caffeine, and Dextromethorphan in Healthy SubjectsCompletedNCT02434861Phase 1
• Effect of BI 1181181 on Midazolam, Warfarin, Omeprazole and DigoxinWithdrawnNCT02345304Phase 1
• A Phase 2 Efficacy Study of CLS003 ICVT in Subjects With Cutaneous Warts.CompletedNCT02333643Phase 2
• The Effect of BI 187004 on the Pharmacokinetics of Cytochrome P450 Substrates (Caffeine, Warfarin, Omeprazole, Metoprolol and Midazolam) and a P Glycoprotein Substrate (Digoxin)CompletedNCT02254148Phase 1
• Investigating the Influence of Oral Semaglutide on Pharmacokinetics of Metformin and Digoxin in Healthy SubjectsCompletedNCT02249910Phase 1
• Acute Cardioversion Versus Wait And See-approach for Symptomatic Atrial Fibrillation in the Emergency DepartmentCompletedNCT02248753Not applicable
• Investigating the Influence of Semaglutide on the Pharmacokinetics of Single Doses of Atorvastatin and Digoxin in Healthy SubjectsCompletedNCT02243098Phase 1
• Drug-drug Interaction Between Digoxin, Furosemide, Metformin, and RosuvastatinCompletedNCT02231931Phase 1
• A Phase 1 Drug-drug Interaction Study in Healthy VolunteersCompletedNCT02227173Phase 1
• Phase II Multicentric Study of Digoxin Per os in Classic or Endemic Kaposi' s SarcomaStatus unknownNCT02212639Phase 2
• Relative Bioavailability of Dabigatran and Digoxin in Healthy Male and Female VolunteersCompletedNCT02171052Phase 1
• A Phase 1B Clinical Trial of Trametinib Plus Digoxin in Patients With Unresectable or Metastatic BRAF Wild-type MelanomaCompletedNCT02138292Phase 1
• Study to Evaluate the Effect of Solifenacin and Mirabegron on the Digoxin Concentrations in Blood in Healthy SubjectsCompletedNCT02127034Phase 1
• A Preliminary Drug Drug Interaction Study With TA-8995CompletedNCT02124954Phase 1
• A 3-Part, Open-Label, Drug-Drug Interaction Study of Concomitant Administration of E2609 With Itraconazole, Rifampin, Digoxin, or DonepezilCompletedNCT02055703Phase 1
• Digoxin Versus Ivabradine in Heart Failure With Reduced Ejection FractionStatus unknownNCT02046044Phase 4
• Clinical Trial to Evaluate the Influence of Genotype and DDIs of Aspirin on the PK/PD of Clopidogrel and PK of DigoxinCompletedNCT01775839Phase 4
• Kinetics of Fluvoxamine and Digoxin in Subjects With Different MDR1 GenotypesCompletedNCT01704638Phase 1
• A Pharmacokinetics Study of Aleglitazar in Combination With Digoxin in Healthy VolunteersCompletedNCT01701739Phase 1
• Efficacy Study of Digoxin & Ivabradine to Treat Heart FailureCompletedNCT01699776Phase 4
• A Study to Evaluate the Effect of a Single Dose of Digoxin on the Actions in the Bodies of Healthy Subjects After Having Taken Several Doses of YM178CompletedNCT01663961Phase 1
• An Open-Label Study of the Effect of Bardoxolone Methyl on the Single Dose Pharmacokinetics of Digoxin and Rosuvastatin in Healthy VolunteersCompletedNCT01598363Phase 1
• An Open-label, Single-centre Study Evaluating the Pharmacokinetics of Digoxin Alone and When Administered at Various Doses of Ezogabine/Retigabine in Healthy Adults. The Pharmacokinetics of Ezogabine/Retigabine and the N-acetyl Metabolite of Ezogabine/Retigabine (NAMR) Will Also be AssessedCompletedNCT01583036Phase 1
• Drug Interaction Study of Isavuconazole and DigoxinCompletedNCT01582412Phase 1
• Study in Healthy Volunteers to Assess the Pharmacokinetics (PK) of Digoxin Administered Alone and in Combination With VandetanibCompletedNCT01561781Phase 1
• A Study to Investigate the Effect of Steady-State TMC278 on the Pharmacokinetics of a Single Dose of DigoxinCompletedNCT01519128Phase 1
• Drug-drug Interaction Study of Tivantinib (ARQ 197) With Omeprazole, S-warfarin, Caffeine, Midazolam, and Digoxin in Cancer SubjectsCompletedNCT01517399Phase 1
• A Study to Investigate the Effect of YM150 on the Plasma Concentration of Digoxin in Healthy SubjectsCompletedNCT01514812Phase 1
• A Phase 1 Study Evaluating Eliglustat's Effects on Pharmacokinetics, Safety & Tolerability of Digoxin in Healthy AdultsCompletedNCT01357811Phase 1
• TMC435-TiDP16-C108 - A Study in Healthy Volunteers Investigating the Pharmacokinetic Interaction Between TMC435 and Digoxin and Between TMC435 and RosuvastatinCompletedNCT01288742Phase 1
• A Drug Interaction Study of Albiglutide and DigoxinCompletedNCT01147718Phase 1
• to Evaluate Effect of Multi Doses Flibans 100 mg Film-c Tablets on Single Dose PK of Digoxin 0.5 mg, Healthy VolunteersCompletedNCT01134965Phase 1
• A Trial of Digoxin Before Second-Trimester AbortionCompletedNCT01047748Not applicable
• A Study to Evaluate the Effect of Fimasartan on Pharmacokinetics, and the Safety of Digoxin in Healthy Male VolunteersCompletedNCT00991783Phase 1
• Study of the Effect of Dapagliflozin on the Pharmacokinetics of Warfarin or Digoxin in Healthy SubjectsCompletedNCT00904176Phase 1
• Drug Interaction Study - Effect of AZD5672 on the Pharmacokinetics of DigoxinCompletedNCT00723424Phase 1
• An Interaction Study With Digoxin and AZD1305CompletedNCT00712465Phase 1
• Study To Examine The Effects Of Lapatinib On The Pharmacokinetics Of Digoxin In Subjects w/ ErbB2 Positive Breast CancerCompletedNCT00650910Phase 1
• Pharmacokinetic and Pharmacodynamic Interaction Study of Digoxin and HawthornCompletedNCT00006330Not applicable

← Digoxin overview